X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-present-data-at-2023-aacr-annual-meeting-showcasing-new-zepzelca-lurbinectedin-data-and-expanded-oncology-pre-clinical-and-clinical-pipeline-301772748.html
https://kalkinemedia.com/au/news/healthcare/brief-pharma-mar-gets-approval-of-zepzelca-for-treatment-of-metastatic-small-cell-lung-cancer-in-switzerland
https://www.fiercepharma.com/pharma/fda-lets-jazzs-lung-cancer-accelerated-approval-stay-now-despite-failed-trial-and-call
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-first-patient-enrolled-in-emerge-201-phase-2-basket-trial-evaluating-zepzelca-lurbinectedin-monotherapy-in-patients-with-select-advanced-or-metastatic-solid-tumors-301509864.html
https://www.prnewswire.co.uk/news-releases/pharmamar-signs-a-new-licensing-and-commercialization-agreement-with-eczacibasi-for-lurbinectedin-in-turkey-826674247.html
https://www.prnewswire.com/news-releases/pharmamar-and-jazz-pharmaceuticals-announce-initiation-of-confirmatory-phase-3-clinical-trial-of-zepzelca-lurbinectedin-for-the-treatment-of-patients-with-relapsed-small-cell-lung-cancer-301442832.html
https://pharmamar.com/wp-content/uploads/2021/09/PR_PharmaMar_announces_the_Canada_approval_of_lurbinectedin_DEF.pdf
https://www.prnewswire.com/news-releases/new-therapy-to-treat-advanced-small-cell-lung-cancer-zepzelca-lurbinectedin-approved-in-singapore-301382325.html
https://www.prnewswire.com/news-releases/new-therapy-to-treat-advanced-small-cell-lung-cancer-approved-for-australian-patients-301376005.html
https://www.onclive.com/view/lurbinectedin-doxorubicin-misses-os-end-point-in-relapsed-sclc-but-shows-superior-safety-vs-soc
https://www.fiercepharma.com/marketing/wclc-jazz-charts-new-path-for-small-cell-lung-cancer-drug-zepzelca-after-late-stage-flop
https://www.reuters.com/business/healthcare-pharmaceuticals/european-oncology-group-adds-pharma-mars-lurbinectedin-treatment-guidelines-2021-04-15/
https://www.globenewswire.com/news-release/2020/10/14/2108736/0/en/ALX-Oncology-to-Present-ALX148-Clinical-Data-at-the-Society-for-Immunotherapy-of-Cancer-SITC-35th-Anniversary-Annual-Meeting.html
https://www.marketscreener.com/PHARMA-MAR-S-A-24798227/news/Pharma-Mar-S-A-PharmaMar-has-filed-lurbinectedin-for-Temporary-Marketing-Authorisation-with-the-Sw-30955486/
https://www.fiercepharma.com/marketing/jazz-nabs-first-solid-tumor-nod-pharmamar-for-zepzelca-to-treat-small-cell-lung-cancer
https://endpts.com/jazz-pharmas-1b-bet-pays-off-with-accelerated-lung-cancer-approval/
https://en.prnasia.com/releases/global/new-small-cell-lung-cancer-drug-accepted-for-tga-evaluation-under-project-orbis-281703.shtml
https://www.prnewswire.com/news-releases/new-small-cell-lung-cancer-drug-accepted-for-tga-evaluation-under-project-orbis-301069865.html
https://www.marketscreener.com/PHARMA-MAR-S-A-24798227/news/Pharma-Mar-S-A-PharmaMar-signs-an-agreement-with-Immedica-Pharma-to-market-lurbinectedin-in-Easter-30492726/
https://www.prnewswire.com/news-releases/pharmamar-and-jazz-pharmaceuticals-announce-fda-acceptance-and-priority-review-of-new-drug-application-for-lurbinectedin-in-relapsed-small-cell-lung-cancer-301005785.html
https://endpts.com/jazz-rolls-the-dice-on-a-billion-dollar-gamble-on-a-new-drug-for-sclc-shooting-for-a-2020-launch/
https://www.fiercebiotech.com/biotech/pharmamar-files-for-fda-approval-small-cell-lung-cancer-drug
http://pharmamar.com/wp-content/uploads/2019/12/PR_Lurbinectedin_NDA_filing_USA_DEF.pdf
http://pharmamar.com/wp-content/uploads/2019/11/PR_Lurbinectedin-orphan-drug-designation_Switzerland_DEF.pdf
https://www.prnewswire.com/news-releases/pharmamar-will-submit-nda-for-lurbinectedin-under-accelerated-approval-in-sclc-in-the-usa-300903739.html
https://www.prnewswire.com/news-releases/positive-results-of-lurbinectedin-phase-ii-trial-pharmamar-for-the-treatment-of-relapsed-small-cell-lung-cancer-are-presented-at-asco-300860243.html
https://endpts.com/after-ovarian-cancer-flop-pharmamars-lurbinectedin-makes-the-cut-in-small-cell-lung-cancer/
https://european-biotechnology.com/up-to-date/latest-news/news/chugai-ends-licence-for-pharmamars-lurbinectedin.html
https://www.prnewswire.com/news-releases/positive-recommendation-of-idmc-to-zepsyre-to-continue-the-phase-iii-trial-within-small-cell-lung-cancer-atlantis-683931541.html
Market Place
Share 
